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Introduction: Antibiotic therapy is of great importance in sepsis but prolonged 
duration can add to the emergence of antibiotic resistance. We aimed to examine 
whether point-of-care (POC) procalcitonin (PCT) guidance can safely reduce the 
duration of antibiotic use in infected critically ill patients. Materials and Methods: 
Eighty adult patients admitted to or acquired sepsis in the intensive care unit (ICU) 
were enrolled in this randomized controlled trial. Patients were allocated to either 
POC PCT-guided intervention arm (n=40) or the control arm, in which antibiotic 
therapy followed local guidelines (n=40). In the PCT-guided arm, antibiotic 
treatment was discontinued if clinical signs of infection improved and the PCT 
concentration decreased by >80% of its peak value, or when it reaches a value of 
<0·5 g/L. Results: The mean duration of antibiotic use for PCT arm was 6.4 (SD 
2.3) days compared to 9 (SD 4.3) days in the control arm (p=0.004). In the first 30 
days after being assigned to a group, the proportion of patients who received a 
repeated course of systemic antibiotics was 33% in the PCT arm vs 38.1% in the 
control arm (p=0.757). Mean length of stay in the ICU was 8.4 (SD 5.3) days in the 
PCT arm vs 10.4 (SD 12.3) days in the control arm (p=0.404). Mortality at 30 days 
was 22.5% in the PCT-arm vs 25% in the control arm (p<0.0001). Conclusion: POC 
PCT guidance stimulates reduction of duration of antibiotic use in ICU, 
accompanied by a significant decrease in mortality. 
  
